Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Celiprolol

A beta-blocker selective for beta-1 receptors, with partial stimulating action on beta-2 receptors, approved in 1982; it is used for hypertension and angina pectoris. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?It has been studied in vascular Ehlers-Danlos syndrome, a rare collagen disorder: the BBEST trial, published in 2010, was stopped early because of the benefit seen.

CeliprololGo to the active ingredient →
CeliprololActive ingredientCeliprololCat. No. P-C111-001CAS 56980-93-9

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.